Please select the option that best describes you:
Topics:
Gastrointestinal Cancers • Medical Oncology
How do you approach a patient with lower risk stage III colon cancer who is unable to tolerate the planned 3 months of oxaliplatin-based therapy due to neuropathy?
Do you add on additional cycles of 5-FU/capecitabine to go beyond 3 months of treatment? Or would you stop at 3 months of therapy, dropping the oxaliplatin at the point of intolerance?
Answer from: Medical Oncologist at Academic Institution
For a stage III patient, I would favor dropping oxaliplatin and just continuing 5FU/leucovorin for the final 3 months (total of 6 mo of treatment). As this is early to see this degree of neuropathy, consider screening for other contributing causes, such as B12 deficiency or diabetes. If this patient...
Sign in or Register to read more